What factors should be considered when determining if a patient is eligible for ruxolitinib for vitiligo?

Featuring Cheri Frey, MD | Assistant Professor, Dermatology & Residency Program Director Director of Cosmetic DermatologyHoward UniversityWashington, DC | Published June 01, 2024